A detailed history of High Tower Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 223,331 shares of BBIO stock, worth $5.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
223,331
Previous 201,254 10.97%
Holding current value
$5.3 Million
Previous $5.1 Million 11.56%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $527,861 - $691,010
22,077 Added 10.97%
223,331 $5.69 Million
Q2 2024

Aug 13, 2024

BUY
$23.0 - $31.04 $45,816 - $61,831
1,992 Added 1.0%
201,254 $5.1 Million
Q1 2024

May 06, 2024

SELL
$27.35 - $40.45 $27,869 - $41,218
-1,019 Reduced 0.51%
199,262 $6.16 Million
Q4 2023

Feb 12, 2024

BUY
$24.02 - $43.89 $25,100 - $45,865
1,045 Added 0.52%
200,281 $8.09 Million
Q3 2023

Nov 08, 2023

SELL
$16.89 - $35.01 $411,727 - $853,438
-24,377 Reduced 10.9%
199,236 $5.25 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $199,350 - $270,150
15,000 Added 7.19%
223,613 $3.85 Million
Q1 2023

May 11, 2023

BUY
$7.17 - $18.55 $1,634 - $4,229
228 Added 0.11%
208,613 $3.46 Million
Q2 2022

Aug 10, 2022

BUY
$5.21 - $12.14 $599 - $1,396
115 Added 0.06%
208,385 $1.89 Million
Q1 2022

May 12, 2022

SELL
$7.34 - $17.16 $78,185 - $182,788
-10,652 Reduced 4.87%
208,270 $2.12 Million
Q4 2021

Feb 10, 2022

BUY
$11.38 - $53.41 $82,891 - $389,038
7,284 Added 3.44%
218,922 $3.65 Million
Q3 2021

Nov 12, 2021

SELL
$46.87 - $64.24 $474,793 - $650,751
-10,130 Reduced 4.57%
211,638 $9.92 Million
Q2 2021

Aug 06, 2021

BUY
$46.47 - $63.93 $139 - $191
3 Added 0.0%
221,768 $13.5 Million
Q1 2021

May 10, 2021

BUY
$55.47 - $72.35 $75,272 - $98,178
1,357 Added 0.62%
221,765 $13.7 Million
Q4 2020

Feb 10, 2021

BUY
$38.38 - $71.11 $3,838 - $7,111
100 Added 0.05%
220,408 $15.7 Million
Q1 2020

May 21, 2020

BUY
$16.11 - $36.23 $3.55 Million - $7.98 Million
220,308 New
220,308 $6.39 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.52B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.